4.6 Article

Prion Protein-Specific Antibodies that Detect Multiple TSE Agents with High Sensitivity

Journal

PLOS ONE
Volume 9, Issue 3, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0091143

Keywords

-

Funding

  1. BBSRC [201/BS3 09722]
  2. British Council
  3. NWO for (UK-Netherlands Partnership Program) [PPS 801]
  4. BBSRC [BBS/E/A/00001658, BBS/E/D/20251967, BBS/E/D/20251968] Funding Source: UKRI
  5. Biotechnology and Biological Sciences Research Council [BBS/E/D/20251967, BBS/E/D/20251968, 1026989, BBS/E/A/00001658] Funding Source: researchfish

Ask authors/readers for more resources

This paper describes the generation, characterisation and potential applications of a panel of novel anti-prion protein monoclonal antibodies (mAbs). The mAbs were generated by immunising PRNP null mice, using a variety of regimes, with a truncated form of recombinant ovine prion protein spanning residues 94-233. Epitopes of specific antibodies were mapped using solid-phase Pepscan analysis and clustered to four distinct regions within the PrP molecule. We have demonstrated the utility of these antibodies by use of Western blotting and immunohistochemistry in tissues from a range of different species affected by transmissible spongiform encephalopathy (TSE). In comparative tests against extensively-used and widely-published, commercially available antibodies, similar or improved results can be obtained using these new mAbs, specifically in terms of sensitivity of detection. Since many of these antibodies recognise native PrP C, they could also be applied to a broad range of immunoassays such as flow cytometry, DELFIA analysis or immunoprecipitation. We are using these reagents to increase our understanding of TSE pathogenesis and for use in potential diagnostic screening assays.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available